Jaisri T Maharaj, MD
Endocrinology · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 23
- 5 carriers
- Offices
- 4
Offices
4 locations · Bass Medical Group · 292 clinicians in this group
Hospitals listed: Good Samaritan Hospital. That is not proof they admit you there this week.
Plans that list them
23 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Maharaj’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
23 of 23 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A122381 · Current
Licensed to practise in California · since 2019 · expires 2027-12-31 · University of West Indies Faculty of Medicine St Agustine.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$92,696
Medicare paid this office $92,696 for 215 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 157 | $48,733 | $113 |
| Telephone medical discussion with physician, 21-30 minutes | 71 | $16,889 | $121 |
| New patient visit (45+ min) | 55 | $8,521 | $155 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 188 | $6,661 | $14 |
| New patient visit (60+ min) | 20 | $3,786 | $189 |
See all 10 services
| Return visit (30+ min) | 157 | $48,733 | $113 |
| Telephone medical discussion with physician, 21-30 minutes | 71 | $16,889 | $121 |
| New patient visit (45+ min) | 55 | $8,521 | $155 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 188 | $6,661 | $14 |
| New patient visit (60+ min) | 20 | $3,786 | $189 |
| Long return visit (40+ min) | 18 | $3,612 | $164 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 37 | $2,822 | $30 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin | 11 | $793 | $72 |
| Injection of drug or substance under skin or into muscle | 15 | $645 | $13 |
| Insertion of needle into vein for collection of blood sample | 20 | $234 | $9 |
Who their Medicare patients are
215 Original Medicare patients in 2024. Average age 75 · Women 72% · Health risk score 1.02. At or below the middle of the specialty; the typical endocrinology clinician is at 1.46.
Conditions among them: High blood pressure 75% · Diabetes 45% · Coronary heart disease 33% · Cancer 17% · Depression 17% · Atrial fibrillation 16% · Chronic kidney disease 14% · Heart failure 10% · Stroke 10% · COPD 7%.
The office billed $369,144, Medicare allowed $123,644 and paid $92,696; for 3,381 services of 14 kinds; $0 of it was for drugs given in the office and $92,696 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 215 | 3,381 | 75 | 1.02 | $369,144 | $92,696 |
| 2023 | 145 | 607 | 75 | 1.12 | $258,319 | $63,417 |
| 2022 | 138 | 483 | 75 | 1.05 | $153,147 | $36,427 |
| 2021 | 238 | 959 | 75 | 1.28 | $207,175 | $56,331 |
| 2020 | 222 | 529 | 71 | 1.67 | $68,627 | $30,949 |
| 2019 | 217 | 459 | 67 | 1.61 | $67,235 | $29,411 |
| 2018 | 143 | 316 | 67 | 1.53 | $43,372 | $16,667 |
| 2017 | 146 | 378 | 67 | 1.39 | $52,801 | $23,096 |
| 2016 | 87 | 256 | 66 | 1.31 | $37,564 | $16,168 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Return visit (30+ min) | 116 | $35,493 | $113 |
| Telephone medical discussion with physician, 21-30 minutes | 54 | $12,065 | $117 |
| New patient visit (45+ min) | 38 | $5,926 | $156 |
| New patient visit (60+ min) | 20 | $3,518 | $176 |
| Long return visit (40+ min) | 17 | $3,407 | $148 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 21 | $1,968 | $31 |
| Insertion of needle into vein for collection of blood sample | 17 | $218 | $8 |
2022: 10 services
| Return visit (30+ min) | 78 | $12,494 | $101 |
| Telephone medical discussion with physician, 21-30 minutes | 43 | $7,325 | $111 |
| Ultrasound scan of head and neck soft tissue | 38 | $4,647 | $122 |
| New patient visit (45+ min) | 24 | $3,468 | $145 |
| Short return visit (20+ min) | 32 | $2,908 | $88 |
| New patient visit (60+ min) | 11 | $1,767 | $161 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 11 | $675 | $32 |
| Hemoglobin a1c level | 44 | $512 | $10 |
| Insertion of needle into vein for collection of blood sample | 54 | $212 | $3 |
| Blood test, thyroid stimulating hormone (tsh) | 11 | $185 | $17 |
2021: 13 services
| Return visit (30+ min) | 144 | $22,269 | $106 |
| Ultrasound scan of head and neck soft tissue | 48 | $6,028 | $123 |
| New patient visit (45+ min) | 37 | $5,263 | $142 |
| Long return visit (40+ min) | 26 | $5,158 | $172 |
| Telephone medical discussion with physician, 21-30 minutes | 25 | $3,949 | $120 |
| New patient visit (60+ min) | 18 | $3,645 | $202 |
| Short return visit (20+ min) | 34 | $3,030 | $89 |
| Blood test, thyroid stimulating hormone (tsh) | 78 | $1,630 | $17 |
| Thyroxine (thyroid chemical), free | 93 | $1,164 | $9 |
| Parathormone (parathyroid hormone) level | 21 | $1,032 | $41 |
| Hemoglobin a1c level | 61 | $631 | $10 |
| Insertion of needle into vein for collection of blood sample | 119 | $498 | $3 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 13 | $486 | $30 |
2020: 6 services
| Return visit (30+ min) | 151 | $16,085 | $73 |
| New patient visit (45+ min) | 74 | $10,148 | $137 |
| Telephone medical discussion with physician, 11-20 minutes | 33 | $1,359 | $40 |
| Telephone medical discussion with physician, 5-10 minutes | 38 | $650 | $17 |
| Hemoglobin a1c level | 28 | $301 | $10 |
| Insertion of needle into vein for collection of blood sample | 39 | $138 | $3 |
2019: 2 services
| Return visit (30+ min) | 165 | $18,449 | $55 |
| New patient visit (45+ min) | 111 | $10,564 | $95 |
2018: 3 services
| Return visit (30+ min) | 112 | $11,599 | $48 |
| New patient visit (45+ min) | 51 | $4,289 | $84 |
| Short return visit (20+ min) | 19 | $773 | $37 |
2017: 4 services
| Return visit (30+ min) | 112 | $13,421 | $55 |
| New patient visit (45+ min) | 69 | $6,422 | $93 |
| Short return visit (20+ min) | 24 | $989 | $33 |
| New patient visit (30+ min) | 13 | $680 | $52 |
2016: 2 services
| Return visit (30+ min) | 62 | $10,175 | $58 |
| New patient visit (45+ min) | 59 | $4,844 | $82 |
Medicaid work
$4,117 in 2021
Medicaid paid $4,117 for 119 billed services this clinician did in 2021, up to 59 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 119 | $4,117 |
| 2021 | 119 | 1 | 59 | $4,117 |
| 2020 | 337 | 5 | 46 | $31,250 |
| 2019 | 186 | 2 | 21 | $7,296 |
| 2018 | 229 | 3 | 32 | $7,228 |
See the largest Medicaid services in earlier years
2020
| Return visit (30+ min) | 220 | $19,484 |
| New patient visit (45+ min) | 57 | $9,748 |
| Hospital outpatient clinic visit for assessment and management of a patient | 33 | $1,711 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion | 12 | $194 |
| Hemoglobin A1C level | 15 | $113 |
2019
| Return visit (30+ min) | 162 | $5,864 |
| Hospital outpatient clinic visit for assessment and management of a patient | 24 | $1,432 |
2018
| Return visit (30+ min) | 200 | $6,782 |
| Hospital outpatient clinic visit for assessment and management of a patient | 16 | $432 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 13 | $14 |
Drugs they prescribed that Part D paid
$360,934
Pharmacies billed $360,934 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
545 generic and 568 brand-name prescriptions · $360,934 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Mounjaro | 65 | $91,669 | $1,410 |
| Ozempic | 52 | $55,336 | $1,064 |
| Jardiance | 33 | $38,110 | $1,155 |
| Januvia | 22 | $28,482 | $1,295 |
| Synthroid | 158 | $17,644 | $112 |
See all 26 drugs
| Mounjaro | 65 | $91,669 | $1,410 |
| Ozempic | 52 | $55,336 | $1,064 |
| Jardiance | 33 | $38,110 | $1,155 |
| Januvia | 22 | $28,482 | $1,295 |
| Synthroid | 158 | $17,644 | $112 |
| Trulicity | 19 | $16,929 | $891 |
| Teriparatide | 11 | $14,944 | $1,359 |
| Tresiba Flextouch U-100 | 15 | $6,865 | $458 |
| Lantus Solostar | 31 | $2,602 | $84 |
| Levothyroxine | 85 | $1,869 | $22 |
| Levoxyl | 27 | $1,578 | $58 |
| Liothyronine | 29 | $1,380 | $48 |
| Nano 2nd Gen Pen Needle | 16 | $1,264 | $79 |
| Metformin Hcl Er | 60 | $921 | $15 |
| Hydrocortisone | 21 | $907 | $43 |
| Glipizide Er | 34 | $645 | $19 |
| Alendronate | 35 | $503 | $14 |
| Metformin | 47 | $483 | $10 |
| Rosuvastatin | 21 | $453 | $22 |
| Ultra-Fine Mini Pen Needle | 11 | $445 | $40 |
| Methimazole | 22 | $307 | $14 |
| Testosterone Cypionate | 13 | $233 | $18 |
| Atorvastatin | 23 | $200 | $9 |
| Losartan | 17 | $181 | $11 |
| Lisinopril | 14 | $86 | $6 |
| Pravastatin | 16 | $43 | $3 |
Year by year
| 2024 | 1,161 | 276 | None | 49% | $360,934 |
| 2023 | 443 | 90 | 0% (0) | 47% | $206,797 |
| 2022 | 381 | 95 | 0% (0) | 53% | $161,463 |
| 2021 | 419 | 148 | 0% (0) | 50% | $141,051 |
| 2020 | 1,631 | 283 | 0% (0) | 52% | $686,384 |
| 2019 | 1,662 | 265 | 0% (0) | 54% | $757,902 |
| 2018 | 1,399 | 169 | 0% (0) | 54% | $542,275 |
| 2017 | 1,087 | 154 | 0% (0) | 56% | $427,117 |
| 2016 | 428 | 82 | 0% (0) | 57% | $125,660 |
| 2015 | 170 | 29 | 0% (0) | 58% | $44,105 |
| 2014 | 275 | 46 | None | 46% | $43,761 |
| 2013 | 615 | 51 | 7% (40) | None | $37,228 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 13 drugs
| Ozempic | 20 | $29,137 | $1,457 |
| Trulicity | 12 | $23,932 | $1,994 |
| Jardiance | 12 | $20,819 | $1,735 |
| Januvia | 11 | $17,362 | $1,578 |
| Lantus Solostar | 17 | $11,114 | $654 |
| Synthroid | 43 | $5,815 | $135 |
| Liothyronine | 24 | $1,784 | $74 |
| Levothyroxine | 55 | $1,670 | $30 |
| Hydrocortisone | 17 | $1,299 | $76 |
| Metformin Hcl Er | 30 | $455 | $15 |
| Metformin | 33 | $403 | $12 |
| Alendronate | 14 | $298 | $21 |
| Glipizide Er | 19 | $276 | $15 |
2022: 8 drugs
| Ozempic | 14 | $27,016 | $1,930 |
| Synthroid | 70 | $8,894 | $127 |
| Liothyronine | 26 | $1,633 | $63 |
| Levothyroxine | 35 | $626 | $18 |
| Levoxyl | 15 | $487 | $32 |
| Metformin | 43 | $381 | $9 |
| Metformin Hcl Er | 14 | $316 | $23 |
| Atorvastatin | 11 | $145 | $13 |
2021: 12 drugs
| Ozempic | 13 | $22,430 | $1,725 |
| Trulicity | 11 | $21,502 | $1,955 |
| Lantus Solostar | 17 | $14,582 | $858 |
| Novolog Flexpen | 12 | $8,542 | $712 |
| Synthroid | 48 | $5,192 | $108 |
| Basaglar Kwikpen U-100 | 13 | $5,168 | $398 |
| Nano 2nd Gen Pen Needle | 12 | $1,213 | $101 |
| Liothyronine | 11 | $1,007 | $92 |
| Ultra-Fine Nano Pen Needle | 12 | $945 | $79 |
| Levothyroxine | 36 | $823 | $23 |
| Metformin | 56 | $541 | $10 |
| Levoxyl | 11 | $175 | $16 |
2020: 32 drugs
| Novolog Flexpen | 71 | $80,951 | $1,140 |
| Lantus Solostar | 117 | $79,126 | $676 |
| Januvia | 81 | $69,848 | $862 |
| Tresiba Flextouch U-200 | 42 | $68,220 | $1,624 |
| Trulicity | 38 | $51,244 | $1,349 |
| Humalog Kwikpen U-100 | 34 | $29,898 | $879 |
| Tresiba Flextouch U-100 | 38 | $24,253 | $638 |
| Tradjenta | 29 | $20,662 | $712 |
| Humalog Kwikpen U-200 | 20 | $19,663 | $983 |
| Basaglar Kwikpen U-100 | 29 | $16,421 | $566 |
| Jardiance | 18 | $14,908 | $828 |
| Victoza 3-Pak | 11 | $13,509 | $1,228 |
| Toujeo Solostar | 22 | $12,516 | $569 |
| Levemir Flextouch | 18 | $10,677 | $593 |
| Levemir | 16 | $7,785 | $487 |
| Ultra-Fine Nano Pen Needle | 74 | $6,325 | $85 |
| Glucagon Emergency Kit | 14 | $4,821 | $344 |
| Levothyroxine | 141 | $3,392 | $24 |
| Metformin Hcl Er | 97 | $1,810 | $19 |
| Synthroid | 33 | $1,810 | $55 |
| Metformin | 186 | $1,788 | $10 |
| Glipizide Er | 40 | $1,106 | $28 |
| Ulticare Pen Needle | 16 | $887 | $55 |
| Rosuvastatin | 32 | $736 | $23 |
| Fenofibrate | 13 | $572 | $44 |
| Methimazole | 32 | $498 | $16 |
| Pioglitazone | 12 | $439 | $37 |
| Insulin | 15 | $315 | $21 |
| Atorvastatin | 22 | $270 | $12 |
| Alendronate | 20 | $255 | $13 |
| Glipizide | 16 | $203 | $13 |
| Lisinopril | 19 | $102 | $5 |
2019: 25 drugs
| Lantus Solostar | 153 | $110,274 | $721 |
| Tresiba Flextouch U-200 | 48 | $109,148 | $2,274 |
| Novolog Flexpen | 85 | $91,028 | $1,071 |
| Januvia | 67 | $63,085 | $942 |
| Humalog Kwikpen U-100 | 52 | $56,050 | $1,078 |
| Trulicity | 35 | $34,744 | $993 |
| Tradjenta | 40 | $30,643 | $766 |
| Humalog Kwikpen U-200 | 25 | $28,769 | $1,151 |
| Tresiba Flextouch U-100 | 29 | $21,886 | $755 |
| Basaglar Kwikpen U-100 | 33 | $16,658 | $505 |
| Toujeo Solostar | 17 | $11,573 | $681 |
| Ultra-Fine Nano Pen Needle | 72 | $7,210 | $100 |
| Levothyroxine | 197 | $4,942 | $25 |
| Glucagon Emergency Kit | 17 | $4,824 | $284 |
| Humulin 70-30 | 11 | $3,966 | $361 |
| Synthroid | 43 | $2,331 | $54 |
| Metformin Hcl Er | 107 | $2,118 | $20 |
| Metformin | 154 | $2,046 | $13 |
| Rosuvastatin | 48 | $1,877 | $39 |
| Methimazole | 44 | $641 | $15 |
| Glipizide Er | 22 | $604 | $27 |
| Pen Needle | 13 | $537 | $41 |
| Alendronate | 21 | $285 | $14 |
| Atorvastatin | 11 | $262 | $24 |
| Lisinopril | 19 | $183 | $10 |
2018: 25 drugs
| Lantus Solostar | 177 | $85,607 | $484 |
| Tresiba Flextouch U-200 | 51 | $78,854 | $1,546 |
| Novolog Flexpen | 62 | $66,209 | $1,068 |
| Humalog Kwikpen U-100 | 63 | $48,148 | $764 |
| Januvia | 49 | $40,758 | $832 |
| Metformin Er Osmotic | 27 | $32,901 | $1,219 |
| Tradjenta | 34 | $25,839 | $760 |
| Trulicity | 21 | $22,417 | $1,067 |
| Tresiba Flextouch U-100 | 22 | $15,538 | $706 |
| Basaglar Kwikpen U-100 | 41 | $13,261 | $323 |
| Lantus | 13 | $11,516 | $886 |
| Novolin 70-30 | 14 | $9,077 | $648 |
| Ultra-Fine Nano Pen Needle | 56 | $5,202 | $93 |
| Humulin 70-30 | 32 | $5,118 | $160 |
| Glucagon Emergency Kit | 16 | $4,578 | $286 |
| Levothyroxine | 111 | $2,737 | $25 |
| Metformin Hcl Er | 102 | $1,648 | $16 |
| Metformin | 107 | $1,356 | $13 |
| Rosuvastatin | 36 | $952 | $26 |
| Synthroid | 20 | $628 | $31 |
| Atorvastatin | 27 | $604 | $22 |
| Pravastatin | 22 | $478 | $22 |
| Methimazole | 33 | $455 | $14 |
| Alendronate | 21 | $240 | $11 |
| Lisinopril | 15 | $116 | $8 |
2017: 26 drugs
| Tresiba Flextouch U-200 | 39 | $75,371 | $1,933 |
| Lantus Solostar | 127 | $63,978 | $504 |
| Novolog Flexpen | 52 | $54,380 | $1,046 |
| Humalog Kwikpen U-100 | 57 | $42,428 | $744 |
| Januvia | 57 | $26,483 | $465 |
| Metformin Hcl Er | 91 | $20,048 | $220 |
| Tradjenta | 27 | $16,915 | $626 |
| Levemir Flextouch | 26 | $11,792 | $454 |
| Humulin 70/30 Kwikpen | 11 | $10,792 | $981 |
| Novolin 70-30 | 18 | $10,671 | $593 |
| Trulicity | 12 | $9,402 | $783 |
| Tresiba Flextouch U-100 | 14 | $9,107 | $650 |
| Farxiga | 11 | $8,591 | $781 |
| Bydureon | 14 | $8,392 | $599 |
| Lantus | 16 | $6,513 | $407 |
| Levothyroxine | 105 | $2,650 | $25 |
| Ultra-Fine Nano Pen Needle | 32 | $2,408 | $75 |
| Bd Ultra-Fine Pen Needle | 17 | $1,786 | $105 |
| Humulin 70-30 | 11 | $1,626 | $148 |
| Metformin | 98 | $1,048 | $11 |
| Ulticare Pen Needle | 13 | $919 | $71 |
| Glipizide Er | 11 | $431 | $39 |
| Atorvastatin | 17 | $364 | $21 |
| Methimazole | 23 | $344 | $15 |
| Pravastatin | 12 | $234 | $20 |
| Lisinopril | 14 | $79 | $6 |
2016: 10 drugs
| Lantus Solostar | 57 | $27,490 | $482 |
| Humalog Kwikpen U-100 | 39 | $19,922 | $511 |
| Levemir Flextouch | 27 | $13,337 | $494 |
| Januvia | 25 | $11,941 | $478 |
| Novolog Flexpen | 15 | $6,914 | $461 |
| Metformin Hcl Er | 37 | $5,405 | $146 |
| Bd Ultra-Fine Pen Needle | 30 | $2,667 | $89 |
| Levothyroxine | 47 | $1,255 | $27 |
| Metformin | 53 | $439 | $8 |
| Methimazole | 11 | $345 | $31 |
2015: 5 drugs
| Lantus Solostar | 17 | $6,539 | $385 |
| Hydrocortisone | 36 | $1,086 | $30 |
| Levothyroxine | 19 | $405 | $21 |
| Metformin | 21 | $74 | $4 |
| Alendronate | 12 | $38 | $3 |
2014: 4 drugs
| Hydrocortisone | 31 | $966 | $31 |
| Levothyroxine | 39 | $734 | $19 |
| Insulin | 13 | $612 | $47 |
| Metformin | 27 | $160 | $6 |
2013: 21 drugs
| Nexium | 11 | $6,088 | $553 |
| Crestor | 15 | $2,431 | $162 |
| Lantus | 11 | $1,638 | $149 |
| Hydrocodone-Acetaminophen | 22 | $481 | $22 |
| Glyburide | 13 | $422 | $32 |
| Lisinopril | 61 | $401 | $7 |
| Atorvastatin | 24 | $379 | $16 |
| Venlafaxine Hcl Er | 11 | $316 | $29 |
| Metformin | 26 | $278 | $11 |
| Potassium Chloride | 12 | $267 | $22 |
| Tramadol | 17 | $244 | $14 |
| Amlodipine Besylate | 37 | $221 | $6 |
| Omeprazole | 22 | $206 | $9 |
| Finasteride | 14 | $173 | $12 |
| Terazosin | 14 | $159 | $11 |
| Carvedilol | 11 | $159 | $14 |
| Baclofen | 12 | $138 | $12 |
| Levothyroxine | 15 | $133 | $9 |
| Losartan | 14 | $122 | $9 |
| Metoprolol | 21 | $115 | $5 |
| Hydrochlorothiazide | 29 | $108 | $4 |
Money from drug and device companies
$1,629 in 2025
| 2025 | 24 | 78 | None | $1,629 |
| 2024 | 17 | 67 | None | $1,236 |
| 2023 | 4 | 30 | None | $423 |
| 2022 | 19 | 32 | None | $644 |
| 2021 | 17 | 64 | None | $1,203 |
| 2020 | 1 | 1 | None | $24 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Synthroid | $240 | 14 payments
|
| Amgen | Evenity | $183 | 6 payments
|
| Antares Pharma | Xyosted | $155 | 16 payments
|
| Dexcom | Dexcom G6 Transmitter | $121 | 4 payments
|
| Radius Health | Tymlos | $94 | 3 payments
|
| Lilly USA | Mounjaro | $91 | 4 payments
|
See all 78 published payments
| Dexcom | Meals · 2025-12-17 | Dexcom G6 Transmitter | $27 |
| Abbvie | Meals · 2025-12-09 | Synthroid | $12 |
| IBSA Pharma | Meals · 2025-12-04 | Tirosint | $54 |
| Antares Pharma | Meals · 2025-12-03 | Xyosted | $11 |
| Amgen | Meals · 2025-11-25 | Evenity | $33 |
| Madrigal Pharmaceuticals | Meals · 2025-11-19 | Rezdiffra | $27 |
| Abbvie | Meals · 2025-11-18 | Synthroid | $18 |
| Ascendis Pharma Endocrinology | Meals · 2025-11-05 | None | $29 |
| Abbvie | Meals · 2025-10-29 | Synthroid | $10 |
| Antares Pharma | Meals · 2025-10-29 | Xyosted | $11 |
| Madrigal Pharmaceuticals | Meals · 2025-10-21 | Rezdiffra | $31 |
| Radius Health | Meals · 2025-10-17 | Tymlos | $28 |
| Abbvie | Meals · 2025-10-15 | Synthroid | $19 |
| Antares Pharma | Meals · 2025-10-15 | Xyosted | $11 |
| Xeris Pharmaceuticals | Meals · 2025-10-15 | Gvoke Hypopen | $20 |
| Almatica Pharma | Meals · 2025-10-13 | Teriparatide | $21 |
| Amgen | Meals · 2025-10-07 | Tepezza | $33 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-10-03 | Kerendia | $15 |
| Abbvie | Meals · 2025-09-25 | Synthroid | $23 |
| Antares Pharma | Meals · 2025-09-24 | Xyosted | $11 |
| Amgen | Meals · 2025-09-23 | Evenity | $29 |
| Tolmar | Meals · 2025-09-11 | Jatenzo | $18 |
| Dexcom | Meals · 2025-09-10 | Dexcom G6 Transmitter | $29 |
| Abbvie | Meals · 2025-09-09 | Synthroid | $9 |
| Novo Nordisk | Meals · 2025-08-28 | Wegovy | $20 |
| Sequel Med Tech | Meals · 2025-08-26 | Twiist | $34 |
| Lilly USA | Meals · 2025-08-21 | Mounjaro | $23 |
| Abbvie | Meals · 2025-08-19 | Synthroid | $26 |
| Antares Pharma | Meals · 2025-08-13 | Xyosted | $9 |
| Antares Pharma | Meals · 2025-07-09 | Xyosted | $8 |
| Abbvie | Meals · 2025-07-08 | Synthroid | $9 |
| Abbott Laboratories | Meals · 2025-07-08 | Freestyle Libre 3 | $16 |
| Dexcom | Meals · 2025-07-03 | Dexcom G6 Transmitter | $33 |
| Sanofi-Aventis U.S. | Meals · 2025-06-25 | Tzield | $15 |
| Lilly USA | Meals · 2025-06-20 | Jardiance | $29 |
| Medtronic | Meals · 2025-06-18 | Minimed 780g | $22 |
| Antares Pharma | Meals · 2025-06-18 | Xyosted | $11 |
| IBSA Pharma | Meals · 2025-06-10 | Tirosint | $20 |
| Chiesi USA | Meals · 2025-06-05 | Mycapssa | $25 |
| Antares Pharma | Meals · 2025-06-04 | Xyosted | $9 |
| Radius Health | Meals · 2025-06-04 | Tymlos | $31 |
| Abbvie | Meals · 2025-05-21 | Synthroid | $31 |
| Antares Pharma | Meals · 2025-05-21 | Xyosted | $11 |
| Dexcom | Meals · 2025-05-21 | Dexcom G6 Transmitter | $32 |
| Amgen | Meals · 2025-05-15 | Evenity | $33 |
| Xeris Pharmaceuticals | Meals · 2025-05-14 | Gvoke Hypopen | $17 |
| Boston Scientific | Meals · 2025-05-13 | General - Pain Management | $22 |
| Antares Pharma | Meals · 2025-05-07 | Xyosted | $11 |
| Ascendis Pharma Endocrinology | Meals · 2025-05-06 | Yorvipath | $28 |
| Abbvie | Meals · 2025-04-29 | Synthroid | $8 |
| Abbvie | Meals · 2025-04-16 | Synthroid | $24 |
| Novo Nordisk | Meals · 2025-04-09 | Wegovy | $27 |
| Antares Pharma | Meals · 2025-04-09 | Xyosted | $10 |
| Beta Bionics | Meals · 2025-04-08 | Ilet Bionic Pancreas | $26 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-04-01 | Kerendia | $23 |
| Lilly USA | Meals · 2025-03-27 | Mounjaro | $20 |
| Kyowa Kirin | Meals · 2025-03-26 | Crysvita | $30 |
| Alexion Pharmaceuticals | Meals · 2025-03-19 | Strensiq | $31 |
| Amgen | Meals · 2025-03-12 | Evenity | $27 |
| Antares Pharma | Meals · 2025-03-12 | Xyosted | $11 |
| Antares Pharma | Meals · 2025-03-12 | Xyosted | $1 |
| Sanofi-Aventis U.S. | Meals · 2025-03-04 | Tzield | $30 |
| Abbvie | Meals · 2025-02-26 | Synthroid | $11 |
| Almatica Pharma | Meals · 2025-02-12 | Teriparatide | $16 |
| Novo Nordisk | Meals · 2025-02-07 | Rybelsus | $33 |
| Abbott Laboratories | Meals · 2025-02-07 | Freestyle Libre 3 | $19 |
| Abbvie | Meals · 2025-02-05 | Synthroid | $30 |
| Antares Pharma | Meals · 2025-02-05 | Xyosted | $11 |
| Verity Pharmaceuticals | Meals · 2025-01-23 | Tlando | $18 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-01-22 | Kerendia | $18 |
| Antares Pharma | Meals · 2025-01-22 | Xyosted | $9 |
| Xeris Pharmaceuticals | Meals · 2025-01-22 | Gvoke Hypopen | $15 |
| Radius Health | Meals · 2025-01-17 | Tymlos | $35 |
| Amgen | Meals · 2025-01-15 | Evenity | $28 |
| Ascendis Pharma Endocrinology | Meals · 2025-01-14 | Yorvipath | $28 |
| Lilly USA | Meals · 2025-01-09 | Mounjaro | $18 |
| Abbvie | Meals · 2025-01-08 | Synthroid | $10 |
| Antares Pharma | Meals · 2025-01-08 | Xyosted | $9 |
See earlier years (2024, 2023, 2022, 2021, 2020)
2024: $1,236
| Novo Nordisk | Ozempic | $260 | 12 payments
|
| Antares Pharma | Xyosted | $196 | 22 payments
|
| Beta Bionics | Ilet Bionic Pancreas | $159 | 5 payments
|
| Dexcom | Dexcom G6 Transmitter | $91 | 3 payments
|
| Lilly USA | Jardiance | $89 | 4 payments
|
| Amgen | Evenity | $82 | 4 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $80 | 3 payments
|
| Radius Health | Tymlos | $50 | 3 payments
|
| Abbott Laboratories | Freestyle Libre 3 | $42 | 2 payments
|
| Abbvie | Synthroid | $34 | 2 payments
|
| Hologic Sales and Service | Trident Specimen Radiography System | $30 | 1 payment
|
| Alexion Pharmaceuticals | Strensiq | $24 | 1 payment
|
| Xeris Pharmaceuticals | Recorlev | $23 | 1 payment
|
| Vivus | Qsymia | $22 | 1 payment
|
| Sanofi-Aventis U.S. | Tzield | $20 | 1 payment
|
| Verity Pharmaceuticals | Tlando | $20 | 1 payment
|
| Almatica Pharma | Teriparatide | $15 | 1 payment
|
2023: $423
| Supernus Pharmaceuticals | Xyosted | $168 | 18 payments
|
| Abbott Laboratories | Freestyle Libre 3 | $154 | 7 payments
|
| Novo Nordisk | Ozempic | $80 | 4 payments
|
| MannKind | Afrezza | $20 | 1 payment
|
2022: $644
| Abbott Laboratories | Freestyle Libre 2 | $208 | 11 payments
|
| Medtronic | Minimed 770g | $52 | 2 payments
|
| Lilly USA | Trulicity | $46 | 2 payments
|
| Merck Sharp & Dohme | Januvia | $35 | 2 payments
|
| Radius Health | Tymlos | $33 | 1 payment
|
| Mannkind | Afrezza | $27 | 1 payment
|
| Dexcom | Dexcom G6 Transmitter | $24 | 1 payment
|
| Novo Nordisk | Rybelsus | $22 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $22 | 1 payment
|
| Xeris Pharmaceuticals | Gvoke Pfs | $20 | 1 payment
|
| Sanofi-Aventis U.S. | Toujeo | $20 | 1 payment
|
| Ultragenyx Pharmaceutical | Crysvita | $19 | 1 payment
|
| iRhythm Technologies | Zio Xt Patch | $19 | 1 payment
|
| IBSA Pharma | Tirosint | $18 | 1 payment
|
| Amgen | Evenity | $18 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $17 | 1 payment
|
| Recordati Rare Diseases Inc. | Isturisa | $16 | 1 payment
|
| EUSA Pharma (US) | Sylvant | $16 | 1 payment
|
| Abbvie | Synthroid | $13 | 1 payment
|
2021: $1,203
| Novo Nordisk | Ozempic | $244 | 19 payments
|
| Lilly USA | Baqsimi | $222 | 10 payments
|
| Zealand Pharma US | Zegalogue | $117 | 3 payments
|
| AbbVie | Synthroid | $95 | 6 payments
|
| Xeris Pharmaceuticals | Gvoke Pfs | $75 | 4 payments
|
| Corcept Therapeutics | Korlym | $65 | 3 payments
|
| Merck Sharp & Dohme | Januvia | $56 | 3 payments
|
| Amgen | Evenity | $50 | 2 payments
|
| VistaPharm | Thyquidity | $46 | 2 payments
|
| Sanofi-Aventis U.S. | Toujeo | $41 | 3 payments
|
| Insulet | Omnipod | $39 | 2 payments
|
| Abbott Laboratories | Freestyle Libre 2 | $35 | 2 payments
|
| Alexion Pharmaceuticals | Strensiq | $27 | 1 payment
|
| Amarin Pharma | Vascepa | $25 | 1 payment
|
| Radius Health | Tymlos | $23 | 1 payment
|
| Clarus Therapeutics | Jatenzo | $23 | 1 payment
|
| Medtronic | Inpen | $20 | 1 payment
|
2020: $24
| Xeris Pharmaceuticals | Gvoke Pfs | $24 | 1 payment
|
Professional record
- NPI
- 1629380464
- Licence
- CA 122381, UT 8631834-1205, WV 26642California A122381: Current · expires 2027-12-31
- Group
- Bass Medical Group
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RE0101X (207RE0101X)
- Mailing address
- 15899 Los Gatos Almaden Rd Ste 12, Los Gatos, CA, 95032
- NPI first listed
- 2010-07-09
- NPI last updated
- 2025-02-26
- NPI record certified
- 2025-02-26
This is when the NPI record was last certified, not a medical board exam.